Renaissance Technologies »

Q32 Bio shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $721k 16k 44.62
2024-06-30 $265k 15k 17.95

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
Novo-nordisk A S Adr (NVO)
United Therapeutics Corporation (UTHR)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Verisign (VRSN)
Sprouts Fmrs Mkt (SFM)
Airbnb Com Cl A (ABNB)
NVIDIA Corporation (NVDA)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Fortinet (FTNT)
Meta Platforms Cl A (META)

View all positions for Renaissance Technologies

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
BlackRock
BlackRock
Arch Venture Corp
Eventide Asset Management
Harvard Management Company
Vanguard Group
Geode Capital Management
Woodline Partners
State Street Corporation
Point72 Asset Management
Platinum Investment Mangement
Ensign Peak Advisors

View all funds holding Q32 Bio